Uneek Mehra - Oct 1, 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
CHIEF FINANCIAL & BUSINESS OFFICER
Signature
/s/ Scott Bizily as Attorney-in-fact for Uneek Mehra
Stock symbol
FDMT
Transactions as of
Oct 1, 2023
Transactions value $
$0
Form type
4
Date filed
10/3/2023, 04:17 PM
Previous filing
Sep 26, 2023
Next filing
Dec 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +230K $0.00 230K Oct 1, 2023 Common Stock 230K $12.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the total number of the underlying shares on September 11, 2024, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on September 11, 2027, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.

Remarks:

CHIEF FINANCIAL & BUSINESS OFFICER